<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.61882/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>27</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of mRNA Expression of CD244 and Its Adapter Molecules in CD8+ T Cells in Acute Leukemia</title>
	<subject_fa>Cancer Biology</subject_fa>
	<subject>Cancer Biology</subject>
	<content_type_fa>مقاله کامل</content_type_fa>
	<content_type>Full Length/Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Background: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;This study investigated the role of the immune-checkpoint receptor (ICR), CD244, and its adapter molecules, in CD8&lt;sup&gt;+&lt;/sup&gt; T cells in acute leukemia.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Methods&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;: Blood samples were obtained from 21 acute lymphoblastic leukemia (ALL) and 6 acute myeloid leukemia (AML) patients and 20 control subjects. Relative gene expression of CD244, immune receptor tyrosine-based switch &lt;em&gt;motif-a&lt;/em&gt;ssociated protein (SA), &lt;span style=&quot;background:white&quot;&gt;EWS/FLI1-activated transcript 2 (&lt;/span&gt;EAT-2)&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;,&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt; and LncRNA-GSTT1-AS1 were evaluated using &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;quantitative reverse transcription polymerase chain reaction.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Expression of CD244, SAP, and EAT-2 were significantly lower in CD8&lt;sup&gt;+&lt;/sup&gt; T cells from ALL patients than those from control subjects. Interestingly, the expression of SAP was much lower than that of CD244, indicating a lower ratio of SAP to CD244. Also, SAP expression was significantly lower in AML patients compared to the control group. Expression of LncRNA-GSTT1-AS1 showed no significant difference in ALL and AML patients compared to control subjects.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;The low SAP/CD244 expression ratio in CD8&lt;sup&gt;+&lt;/sup&gt; T cells in ALL suggests an inhibitory role for CD244 in ALL.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>CD244 Expression in Acute Leukemia</keyword>
	<start_page>214</start_page>
	<end_page>218</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-5163-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Mohammadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maryammohammadi513@gmail.com</email>
	<code></code>
	<orcid>0000-0002-2889-7177</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Asgarian-Omran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>asgarianhossein@yahoo.com</email>
	<code></code>
	<orcid>0000-0003-3816-8792</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmad</first_name>
	<middle_name></middle_name>
	<last_name>Najfi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahmad.najafi.2012@gmail.com</email>
	<code></code>
	<orcid>0000-0001-9821-336X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Reza</first_name>
	<middle_name></middle_name>
	<last_name>Valadan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>valadan.reza@gmail.com</email>
	<code></code>
	<orcid>0000-0002-9074-6994</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Molecular and Cell-Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Karami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>karami_oncologist@yahoo.com</email>
	<code></code>
	<orcid>0000-0001-9765-776X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Mazandaran Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammadd</first_name>
	<middle_name></middle_name>
	<last_name>Naderisoraki</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr.naderisorki@gmail.com</email>
	<code></code>
	<orcid>0000-0001-8638-4057</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Mazandaran Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ehsan</first_name>
	<middle_name></middle_name>
	<last_name>Zaboli</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>paya_1358@yahoo.com</email>
	<code></code>
	<orcid>0000-0003-4009-717X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Eslami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mo.eslami@mazums.ac.ir</email>
	<code></code>
	<orcid>0000-0001-5887-8869</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohsen</first_name>
	<middle_name></middle_name>
	<last_name>Tehrani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drmtehrani@gmail.com</email>
	<code></code>
	<orcid>0000-0002-9292-4520</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
